Y-mAbs, G Medical top healthcare gainers; Pyxis, AnPac among losers

seekingalpha2023-03-31

Gainers: Y-mAbs Therapeutics (YMAB) +43%. G Medical Innovations (GMVD) +41%. Palisade Bio (PALI) +20%. Inozyme Pharma (INZY) +17%. Paratek Pharmaceuticals (PRTK) +17%. Losers: Pyxis Oncology (PYXS) -...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2323566480?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/487831223/image_487831223.jpg","is_english":true,"pubTime":"2023-03-31 22:05","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2323566480","market":"us","top_or_hot":-1,"title":"Y-mAbs, G Medical top healthcare gainers; Pyxis, AnPac among losers","media":"seekingalpha","content":"<div>\n<p>Gainers: Y-mAbs Therapeutics (YMAB) +43%. G Medical Innovations (GMVD) +41%. Palisade Bio (PALI) +20%. Inozyme Pharma (INZY) +17%. Paratek Pharmaceuticals (PRTK) +17%.\n\nLosers: Pyxis Oncology (PYXS) -...</p>\n\n<a href=\"https://seekingalpha.com/news/3953201-y-mabs-g-medical-top-healthcare-gainers-pyxis-anpac-among-losers\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Y-mAbs, G Medical top healthcare gainers; Pyxis, AnPac among losers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nY-mAbs, G Medical top healthcare gainers; Pyxis, AnPac among losers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-31 22:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3953201-y-mabs-g-medical-top-healthcare-gainers-pyxis-anpac-among-losers><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers: Y-mAbs Therapeutics (YMAB) +43%. G Medical Innovations (GMVD) +41%. Palisade Bio (PALI) +20%. Inozyme Pharma (INZY) +17%. Paratek Pharmaceuticals (PRTK) +17%.\n\nLosers: Pyxis Oncology (PYXS) -...</p>\n\n<a href=\"https://seekingalpha.com/news/3953201-y-mabs-g-medical-top-healthcare-gainers-pyxis-anpac-among-losers\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/3953201-y-mabs-g-medical-top-healthcare-gainers-pyxis-anpac-among-losers","article_id":"2323566480","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/487831223/image_487831223.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2323566480","pubTimestamp":1680271549,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Gainers: Y-mAbs Therapeutics (YMAB) +43%. G Medical Innovations (GMVD) +41%. Palisade Bio (PALI) +20","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"161125":"标普500","513500":"标普500ETF","BK4139":"生物科技","BK4585":"ETF&股票定投概念","PRTK":"Paratek Pharmaceuticals Inc.","BK4504":"桥水持仓","PYXS":"Pyxis Oncology, Inc.","SH":"标普500反向ETF","SSO":"两倍做多标普500ETF","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","CKPT":"Checkpoint Therapeutics, Inc.","SPXU":"三倍做空标普500ETF","OEX":"标普100","YMAB":"Y-mAbs Therapeutics, Inc.","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","BK4007":"制药","BK4581":"高盛持仓","IVV":"标普500指数ETF","BK4185":"保健护理机构","BK4588":"碎股","ENSC":"Ensysce Biosciences Inc.","SDS":"两倍做空标普500ETF","INZY":"Inozyme Pharma","UPRO":"三倍做多标普500ETF","PALI":"Palisade Bio Inc.",".SPX":"S&P 500 Index","BK4534":"瑞士信贷持仓"},"translate_title":"Y-mAbs，G医疗保健顶级赢家；Pyxis，AnPac在失败者中","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161125":0.6,"513500":0.6,"ENSC":1,"YMAB":1,"PYXS":1,"PRTK":1,"PALI":1,"INZY":1,"CKPT":1,"CANO":1,"ANPC":1,"OEF":0.6,"UPRO":0.6,"SSO":0.6,"SPY":0.6,"SPXU":0.6,"SH":0.6,"SDS":0.6,"OEX":0.6,"IVV":0.6,"ESmain":0.6,".SPX":0.6},"content_text":"Gainers: Y-mAbs Therapeutics (YMAB) +43%. G Medical Innovations (GMVD) +41%. Palisade Bio (PALI) +20%. Inozyme Pharma (INZY) +17%. Paratek Pharmaceuticals (PRTK) +17%.\n\nLosers: Pyxis Oncology (PYXS) -30% AnPac Bio-Medical Science (ANPC) -29%. Checkpoint Therapeutics (CKPT) -27%. Cano Health (CANO) -25%. Ensysce Biosciences (ENSC) -25%.\nS&P 500 Healthcare sector is currently up +0.62% to 1,503.28. Health Care Equipment & Services is up +0.68% and Pharmaceuticals, Biotechnology & Life Sciences are up +0.58%.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2323566480"}